FDA Revises Letter of Authorization for the Emergency Use Authorization for Paxlovid

FDA Revises Letter of Authorization for the Emergency Use Authorization for Paxlovid

Source: 
Drugs.com
snippet: 

Today, FDA is announcing a revision to the Paxlovid emergency use authorization (EUA), stating that Paxlovid manufactured and labeled in accordance with the EUA (EUA-labeled Paxlovid) currently in U.S. distribution will remain authorized for use through the labeled or extended expiration date, as applicable, or through March 8, 2024, whichever is earlier.